Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Runzao Qingfei Gao is a traditional Chinese medicine (TCM) developed by Shandong Dong'e Ejiao Co., Ltd. for the treatment of respiratory conditions. Formulated as a concentrated herbal paste (Gao), it is specifically indicated for cough resulting from acute tracheobronchitis or acute exacerbations of chronic bronchitis. According to TCM principles, the formulation functions to moisten dryness and clear lung heat, addressing symptoms of dry cough and thick sputum. The product has been evaluated in Phase 2 clinical trials in China (e.g., CTR20180010) to assess its safety, efficacy, and optimal dosing compared to other TCM mixtures and matched placebos.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Runzao Qingfei Gao.